Home/Filings/4/0001104659-22-026697
4//SEC Filing

Ianelli Christopher 4

Accession 0001104659-22-026697

CIK 0001558569other

Filed

Feb 23, 7:00 PM ET

Accepted

Feb 24, 5:00 PM ET

Size

11.3 KB

Accession

0001104659-22-026697

Insider Transaction Report

Form 4
Period: 2022-02-22
Ianelli Christopher
DirectorPresident & CEO
Transactions
  • Exercise/Conversion

    Common Stock

    2022-02-22$1.00/sh+3,099$3,099398,540 total
  • Exercise/Conversion

    Common Stock

    2022-02-23$1.00/sh+48,106$48,106446,646 total
  • Exercise/Conversion

    Option

    2022-02-223,09949,515 total
    Exercise: $1.00Exp: 2029-01-31Common Stock (3,099 underlying)
  • Exercise/Conversion

    Option

    2022-02-2348,1061,409 total
    Exercise: $1.00Exp: 2029-07-12Common Stock (48,106 underlying)
Footnotes (5)
  • [F1]Acquisition of shares of common stock by the Reporting Person upon the exercise of stock options.
  • [F2]Represents the $1.00 exercise price per share of the stock options exercised, which was paid by the Reporting Person upon exercise of such stock options.
  • [F3]Represents a portion of the stock options granted to the Reporting Person on April 26, 2019, pursuant to the Issuer's 2013 Stock Incentive Plan, which were fully vested on November 30, 2021.
  • [F4]Represents the stock options granted to the Reporting Person on July 13, 2019, pursuant to the Issuer's 2010 Stock Incentive Plan, which were fully vested on July 14, 2019.
  • [F5]Represents remaining granted stock options across all grants.

Issuer

iSpecimen Inc.

CIK 0001558569

Entity typeother

Related Parties

1
  • filerCIK 0001857027

Filing Metadata

Form type
4
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 5:00 PM ET
Size
11.3 KB